Advancing Vaccine Adjuvant Research for Tuberculosis (TB)
Type: Forecast
Overview
Description
Advancing Vaccine Adjuvant Research for Tuberculosis (TB)
Est. Value
Min: $1,500,000
Max: $3,000,000
Max: $3,000,000
Est. Award Date
7/1/2022
Set Aside
Full and Open
Pricing
Cost Reimbursement (C)
Forecast Type
New Requirement
Place of Performance
Rockville, MD USA
Forecast Source
Health and Human Services
National Institutes of Health is forecasted to issue a new procurement for Advancing Vaccine Adjuvant Research for Tuberculosis (TB) around 7/1/2022 worth up to $3,000,000.
Agency
Source Level 1 Agency
Health and Human Services
Source Level 2 Agency
National Institutes of Health
Source Level 3 Agency
NIH/NIAID
Contacts
Point of Contact
Bannister, Emily Profile
Point of Contact Email
Point of Contact Phone
240-669-5135
Small Business Offices
Potential Bidders and Partners
Similar Active Opportunities
Additional Detail
Date Published
6/2/22
Source Est. Period of Performance Start
7/21/22
Source Est. Period of Performance End
7/20/23